(Q37153391)

18 August 2017

title

Short course of weekly low-dose intravenous pulse cyclophosphamide in the treatment of lupus nephritis: a preliminary study (English)

1 reference

18 August 2017

1 reference

4

G R Hughes

1 reference

18 August 2017

F A Houssiau

1

1 reference

18 August 2017

D P D'Cruz

series ordinal

2

1 reference

18 August 2017

H J Haga

series ordinal

3

1 reference

18 August 2017

publication date

1 November 1991

1 reference

18 August 2017

1 reference

18 August 2017

volume

1

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

31-35

1 reference

NIH conference. Lupus nephritis

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F096120339100100106

Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339100100106

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339100100106

Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339100100106

In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339100100106

Cytotoxic drugs: their clinical application to the rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339100100106

10.1177/096120339100100106

21 January 2018

Identifiers

DOI

0 references

1 reference